• +91 9169164321 (Asia)
  • +1(646)-781-7170 (Int'l)
  • help@24lifesciences.com
Cart (0)

Global Influenza Medication Market Insights and Forecast to 2026

report cover
  • 30 July 2020
  • Healthcare
  • 118 Pages
  • Report Code: 24LS-15960
  • Formate :   
Download FREE Report Sample Download PDF File

Influenza Medication -MARKET ADVISORY SERVICES

Influenza Medication market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Influenza Medication market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Influenza Medication market is segmented into
Zanamivir
Oseltamivir
Peramivir
Amantadine
Rimantadine
Inosine
Other

Segment by Application, the Influenza Medication market is segmented into
Hospitals
Clinics
Pharmacies
Others

Regional and Country-level Analysis
The Influenza Medication market is analysed and market size information is provided by regions (countries).
The key regions covered in the Influenza Medication market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Influenza Medication Market Share Analysis
Influenza Medication market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Influenza Medication business, the date to enter into the Influenza Medication market, Influenza Medication product introduction, recent developments, etc.

The major vendors covered:
Daiichi Sankyo Company
GlaxoSmithKline
Natco Pharma
F. Hoffmann-La Roche
Teva Pharmaceutical
Sandoz International GmbH (Novartis AG)
Sun Pharmaceutical Industries
Mylan
1 Study Coverage
1.1 Influenza Medication Product Introduction
1.2 Market Segments
1.3 Key Influenza Medication Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Influenza Medication Market Size Growth Rate by Type
1.4.2 Zanamivir
1.4.3 Oseltamivir
1.4.4 Peramivir
1.4.5 Amantadine
1.4.6 Rimantadine
1.4.7 Inosine
1.4.8 Other
1.5 Market by Application
1.5.1 Global Influenza Medication Market Size Growth Rate by Application
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Pharmacies
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Influenza Medication Market Size, Estimates and Forecasts
2.1.1 Global Influenza Medication Revenue 2015-2026
2.1.2 Global Influenza Medication Sales 2015-2026
2.2 Global Influenza Medication, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Influenza Medication Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Influenza Medication Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Influenza Medication Competitor Landscape by Players
3.1 Influenza Medication Sales by Manufacturers
3.1.1 Influenza Medication Sales by Manufacturers (2015-2020)
3.1.2 Influenza Medication Sales Market Share by Manufacturers (2015-2020)
3.2 Influenza Medication Revenue by Manufacturers
3.2.1 Influenza Medication Revenue by Manufacturers (2015-2020)
3.2.2 Influenza Medication Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Influenza Medication Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Influenza Medication Revenue in 2019
3.2.5 Global Influenza Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Influenza Medication Price by Manufacturers
3.4 Influenza Medication Manufacturing Base Distribution, Product Types
3.4.1 Influenza Medication Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Influenza Medication Product Type
3.4.3 Date of International Manufacturers Enter into Influenza Medication Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Influenza Medication Market Size by Type (2015-2020)
4.1.1 Global Influenza Medication Sales by Type (2015-2020)
4.1.2 Global Influenza Medication Revenue by Type (2015-2020)
4.1.3 Influenza Medication Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Influenza Medication Market Size Forecast by Type (2021-2026)
4.2.1 Global Influenza Medication Sales Forecast by Type (2021-2026)
4.2.2 Global Influenza Medication Revenue Forecast by Type (2021-2026)
4.2.3 Influenza Medication Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Influenza Medication Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Influenza Medication Market Size by Application (2015-2020)
5.1.1 Global Influenza Medication Sales by Application (2015-2020)
5.1.2 Global Influenza Medication Revenue by Application (2015-2020)
5.1.3 Influenza Medication Price by Application (2015-2020)
5.2 Influenza Medication Market Size Forecast by Application (2021-2026)
5.2.1 Global Influenza Medication Sales Forecast by Application (2021-2026)
5.2.2 Global Influenza Medication Revenue Forecast by Application (2021-2026)
5.2.3 Global Influenza Medication Price Forecast by Application (2021-2026)

6 North America
6.1 North America Influenza Medication by Country
6.1.1 North America Influenza Medication Sales by Country
6.1.2 North America Influenza Medication Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Influenza Medication Market Facts & Figures by Type
6.3 North America Influenza Medication Market Facts & Figures by Application

7 Europe
7.1 Europe Influenza Medication by Country
7.1.1 Europe Influenza Medication Sales by Country
7.1.2 Europe Influenza Medication Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Influenza Medication Market Facts & Figures by Type
7.3 Europe Influenza Medication Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Influenza Medication by Region
8.1.1 Asia Pacific Influenza Medication Sales by Region
8.1.2 Asia Pacific Influenza Medication Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Influenza Medication Market Facts & Figures by Type
8.3 Asia Pacific Influenza Medication Market Facts & Figures by Application

9 Latin America
9.1 Latin America Influenza Medication by Country
9.1.1 Latin America Influenza Medication Sales by Country
9.1.2 Latin America Influenza Medication Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Influenza Medication Market Facts & Figures by Type
9.3 Central & South America Influenza Medication Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Influenza Medication by Country
10.1.1 Middle East and Africa Influenza Medication Sales by Country
10.1.2 Middle East and Africa Influenza Medication Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Influenza Medication Market Facts & Figures by Type
10.3 Middle East and Africa Influenza Medication Market Facts & Figures by Application

11 Company Profiles
11.1 Daiichi Sankyo Company
11.1.1 Daiichi Sankyo Company Corporation Information
11.1.2 Daiichi Sankyo Company Description and Business Overview
11.1.3 Daiichi Sankyo Company Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Daiichi Sankyo Company Influenza Medication Products Offered
11.1.5 Daiichi Sankyo Company Related Developments
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Corporation Information
11.2.2 GlaxoSmithKline Description and Business Overview
11.2.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
11.2.4 GlaxoSmithKline Influenza Medication Products Offered
11.2.5 GlaxoSmithKline Related Developments
11.3 Natco Pharma
11.3.1 Natco Pharma Corporation Information
11.3.2 Natco Pharma Description and Business Overview
11.3.3 Natco Pharma Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Natco Pharma Influenza Medication Products Offered
11.3.5 Natco Pharma Related Developments
11.4 F. Hoffmann-La Roche
11.4.1 F. Hoffmann-La Roche Corporation Information
11.4.2 F. Hoffmann-La Roche Description and Business Overview
11.4.3 F. Hoffmann-La Roche Sales, Revenue and Gross Margin (2015-2020)
11.4.4 F. Hoffmann-La Roche Influenza Medication Products Offered
11.4.5 F. Hoffmann-La Roche Related Developments
11.5 Teva Pharmaceutical
11.5.1 Teva Pharmaceutical Corporation Information
11.5.2 Teva Pharmaceutical Description and Business Overview
11.5.3 Teva Pharmaceutical Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Teva Pharmaceutical Influenza Medication Products Offered
11.5.5 Teva Pharmaceutical Related Developments
11.6 Sandoz International GmbH (Novartis AG)
11.6.1 Sandoz International GmbH (Novartis AG) Corporation Information
11.6.2 Sandoz International GmbH (Novartis AG) Description and Business Overview
11.6.3 Sandoz International GmbH (Novartis AG) Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Sandoz International GmbH (Novartis AG) Influenza Medication Products Offered
11.6.5 Sandoz International GmbH (Novartis AG) Related Developments
11.7 Sun Pharmaceutical Industries
11.7.1 Sun Pharmaceutical Industries Corporation Information
11.7.2 Sun Pharmaceutical Industries Description and Business Overview
11.7.3 Sun Pharmaceutical Industries Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Sun Pharmaceutical Industries Influenza Medication Products Offered
11.7.5 Sun Pharmaceutical Industries Related Developments
11.8 Mylan
11.8.1 Mylan Corporation Information
11.8.2 Mylan Description and Business Overview
11.8.3 Mylan Sales, Revenue and Gross Margin (2015-2020)
11.8.4 Mylan Influenza Medication Products Offered
11.8.5 Mylan Related Developments
11.1 Daiichi Sankyo Company
11.1.1 Daiichi Sankyo Company Corporation Information
11.1.2 Daiichi Sankyo Company Description and Business Overview
11.1.3 Daiichi Sankyo Company Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Daiichi Sankyo Company Influenza Medication Products Offered
11.1.5 Daiichi Sankyo Company Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Influenza Medication Market Estimates and Projections by Region
12.1.1 Global Influenza Medication Sales Forecast by Regions 2021-2026
12.1.2 Global Influenza Medication Revenue Forecast by Regions 2021-2026
12.2 North America Influenza Medication Market Size Forecast (2021-2026)
12.2.1 North America: Influenza Medication Sales Forecast (2021-2026)
12.2.2 North America: Influenza Medication Revenue Forecast (2021-2026)
12.2.3 North America: Influenza Medication Market Size Forecast by Country (2021-2026)
12.3 Europe Influenza Medication Market Size Forecast (2021-2026)
12.3.1 Europe: Influenza Medication Sales Forecast (2021-2026)
12.3.2 Europe: Influenza Medication Revenue Forecast (2021-2026)
12.3.3 Europe: Influenza Medication Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Influenza Medication Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Influenza Medication Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Influenza Medication Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Influenza Medication Market Size Forecast by Region (2021-2026)
12.5 Latin America Influenza Medication Market Size Forecast (2021-2026)
12.5.1 Latin America: Influenza Medication Sales Forecast (2021-2026)
12.5.2 Latin America: Influenza Medication Revenue Forecast (2021-2026)
12.5.3 Latin America: Influenza Medication Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Influenza Medication Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Influenza Medication Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Influenza Medication Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Influenza Medication Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Influenza Medication Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Influenza Medication Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables

Table 1. Influenza Medication Market Segments

Table 2. Ranking of Global Top Influenza Medication Manufacturers by Revenue (US$ Million) in 2019

Table 3. Global Influenza Medication Market Size Growth Rate by Type 2020-2026 (K Units) & (US$ Million)

Table 4. Major Manufacturers of Zanamivir

Table 5. Major Manufacturers of Oseltamivir

Table 6. Major Manufacturers of Peramivir

Table 7. Major Manufacturers of Amantadine

Table 8. Major Manufacturers of Rimantadine

Table 9. Major Manufacturers of Inosine

Table 10. Major Manufacturers of Other

Table 11. Global Influenza Medication Market Size Growth Rate by Application 2020-2026 (K Units)

Table 12. Global Influenza Medication Market Size by Region (K Units) & (US$ Million): 2020 VS 2026

Table 13. Global Influenza Medication Sales by Regions 2015-2020 (K Units)

Table 14. Global Influenza Medication Sales Market Share by Regions (2015-2020)

Table 15. Global Influenza Medication Revenue by Regions 2015-2020 (US$ Million)

Table 16. Global Influenza Medication Sales by Manufacturers (2015-2020) (K Units)

Table 17. Global Influenza Medication Sales Share by Manufacturers (2015-2020)

Table 18. Global Influenza Medication Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)

Table 19. Global Influenza Medication by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Influenza Medication as of 2019)

Table 20. Influenza Medication Revenue by Manufacturers (2015-2020) (US$ Million)

Table 21. Influenza Medication Revenue Share by Manufacturers (2015-2020)

Table 22. Key Manufacturers Influenza Medication Price (2015-2020) (USD/Unit)

Table 23. Influenza Medication Manufacturers Manufacturing Base Distribution and Headquarters

Table 24. Manufacturers Influenza Medication Product Type

Table 25. Date of International Manufacturers Enter into Influenza Medication Market

Table 26. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 27. Global Influenza Medication Sales by Type (2015-2020) (K Units)

Table 28. Global Influenza Medication Sales Share by Type (2015-2020)

Table 29. Global Influenza Medication Revenue by Type (2015-2020) (US$ Million)

Table 30. Global Influenza Medication Revenue Share by Type (2015-2020)

Table 31. Influenza Medication Average Selling Price (ASP) by Type 2015-2020 (USD/Unit)

Table 32. Global Influenza Medication Sales by Application (2015-2020) (K Units)

Table 33. Global Influenza Medication Sales Share by Application (2015-2020)

Table 34. North America Influenza Medication Sales by Country (2015-2020) (K Units)

Table 35. North America Influenza Medication Sales Market Share by Country (2015-2020)

Table 36. North America Influenza Medication Revenue by Country (2015-2020) (US$ Million)

Table 37. North America Influenza Medication Revenue Market Share by Country (2015-2020)

Table 38. North America Influenza Medication Sales by Type (2015-2020) (K Units)

Table 39. North America Influenza Medication Sales Market Share by Type (2015-2020)

Table 40. North America Influenza Medication Sales by Application (2015-2020) (K Units)

Table 41. North America Influenza Medication Sales Market Share by Application (2015-2020)

Table 42. Europe Influenza Medication Sales by Country (2015-2020) (K Units)

Table 43. Europe Influenza Medication Sales Market Share by Country (2015-2020)

Table 44. Europe Influenza Medication Revenue by Country (2015-2020) (US$ Million)

Table 45. Europe Influenza Medication Revenue Market Share by Country (2015-2020)

Table 46. Europe Influenza Medication Sales by Type (2015-2020) (K Units)

Table 47. Europe Influenza Medication Sales Market Share by Type (2015-2020)

Table 48. Europe Influenza Medication Sales by Application (2015-2020) (K Units)

Table 49. Europe Influenza Medication Sales Market Share by Application (2015-2020)

Table 50. Asia Pacific Influenza Medication Sales by Region (2015-2020) (K Units)

Table 51. Asia Pacific Influenza Medication Sales Market Share by Region (2015-2020)

Table 52. Asia Pacific Influenza Medication Revenue by Region (2015-2020) (US$ Million)

Table 53. Asia Pacific Influenza Medication Revenue Market Share by Region (2015-2020)

Table 54. Asia Pacific Influenza Medication Sales by Type (2015-2020) (K Units)

Table 55. Asia Pacific Influenza Medication Sales Market Share by Type (2015-2020)

Table 56. Asia Pacific Influenza Medication Sales by Application (2015-2020) (K Units)

Table 57. Asia Pacific Influenza Medication Sales Market Share by Application (2015-2020)

Table 58. Latin America Influenza Medication Sales by Country (2015-2020) (K Units)

Table 59. Latin America Influenza Medication Sales Market Share by Country (2015-2020)

Table 60. Latin Americaa Influenza Medication Revenue by Country (2015-2020) (US$ Million)

Table 61. Latin America Influenza Medication Revenue Market Share by Country (2015-2020)

Table 62. Latin America Influenza Medication Sales by Type (2015-2020) (K Units)

Table 63. Latin America Influenza Medication Sales Market Share by Type (2015-2020)

Table 64. Latin America Influenza Medication Sales by Application (2015-2020) (K Units)

Table 65. Latin America Influenza Medication Sales Market Share by Application (2015-2020)

Table 66. Middle East and Africa Influenza Medication Sales by Country (2015-2020) (K Units)

Table 67. Middle East and Africa Influenza Medication Sales Market Share by Country (2015-2020)

Table 68. Middle East and Africa Influenza Medication Revenue by Country (2015-2020) (US$ Million)

Table 69. Middle East and Africa Influenza Medication Revenue Market Share by Country (2015-2020)

Table 70. Middle East and Africa Influenza Medication Sales by Type (2015-2020) (K Units)

Table 71. Middle East and Africa Influenza Medication Sales Market Share by Type (2015-2020)

Table 72. Middle East and Africa Influenza Medication Sales by Application (2015-2020) (K Units)

Table 73. Middle East and Africa Influenza Medication Sales Market Share by Application (2015-2020)

Table 74. Daiichi Sankyo Company Corporation Information

Table 75. Daiichi Sankyo Company Description and Major Businesses

Table 76. Daiichi Sankyo Company Influenza Medication Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 77. Daiichi Sankyo Company Product

Table 78. Daiichi Sankyo Company Recent Development

Table 79. GlaxoSmithKline Corporation Information

Table 80. GlaxoSmithKline Description and Major Businesses

Table 81. GlaxoSmithKline Influenza Medication Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 82. GlaxoSmithKline Product

Table 83. GlaxoSmithKline Recent Development

Table 84. Natco Pharma Corporation Information

Table 85. Natco Pharma Description and Major Businesses

Table 86. Natco Pharma Influenza Medication Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 87. Natco Pharma Product

Table 88. Natco Pharma Recent Development

Table 89. F. Hoffmann-La Roche Corporation Information

Table 90. F. Hoffmann-La Roche Description and Major Businesses

Table 91. F. Hoffmann-La Roche Influenza Medication Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 92. F. Hoffmann-La Roche Product

Table 93. F. Hoffmann-La Roche Recent Development

Table 94. Teva Pharmaceutical Corporation Information

Table 95. Teva Pharmaceutical Description and Major Businesses

Table 96. Teva Pharmaceutical Influenza Medication Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 97. Teva Pharmaceutical Product

Table 98. Teva Pharmaceutical Recent Development

Table 99. Sandoz International GmbH (Novartis AG) Corporation Information

Table 100. Sandoz International GmbH (Novartis AG) Description and Major Businesses

Table 101. Sandoz International GmbH (Novartis AG) Influenza Medication Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 102. Sandoz International GmbH (Novartis AG) Product

Table 103. Sandoz International GmbH (Novartis AG) Recent Development

Table 104. Sun Pharmaceutical Industries Corporation Information

Table 105. Sun Pharmaceutical Industries Description and Major Businesses

Table 106. Sun Pharmaceutical Industries Influenza Medication Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 107. Sun Pharmaceutical Industries Product

Table 108. Sun Pharmaceutical Industries Recent Development

Table 109. Mylan Corporation Information

Table 110. Mylan Description and Major Businesses

Table 111. Mylan Influenza Medication Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)

Table 112. Mylan Product

Table 113. Mylan Recent Development

Table 114. Global Influenza Medication Sales Forecast by Regions (2021-2026) (K Units)

Table 115. Global Influenza Medication Sales Market Share Forecast by Regions (2021-2026)

Table 116. Global Influenza Medication Revenue Forecast by Regions (2021-2026) (US$ Million)

Table 117. Global Influenza Medication Revenue Market Share Forecast by Regions (2021-2026)

Table 118. North America: Influenza Medication Sales Forecast by Country (2021-2026) (K Units)

Table 119. North America: Influenza Medication Revenue Forecast by Country (2021-2026) (US$ Million)

Table 120. Europe: Influenza Medication Sales Forecast by Country (2021-2026) (K Units)

Table 121. Europe: Influenza Medication Revenue Forecast by Country (2021-2026) (US$ Million)

Table 122. Asia Pacific: Influenza Medication Sales Forecast by Region (2021-2026) (K Units)

Table 123. Asia Pacific: Influenza Medication Revenue Forecast by Region (2021-2026) (US$ Million)

Table 124. Latin America: Influenza Medication Sales Forecast by Country (2021-2026) (K Units)

Table 125. Latin America: Influenza Medication Revenue Forecast by Country (2021-2026) (US$ Million)

Table 126. Middle East and Africa: Influenza Medication Sales Forecast by Country (2021-2026) (K Units)

Table 127. Middle East and Africa: Influenza Medication Revenue Forecast by Country (2021-2026) (US$ Million)

Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)

Table 129. Key Challenges

Table 130. Market Risks

Table 131. Main Points Interviewed from Key Influenza Medication Players

Table 132. Influenza Medication Customers List

Table 133. Influenza Medication Distributors List

Table 134. Research Programs/Design for This Report

Table 135. Key Data Information from Secondary Sources

Table 136. Key Data Information from Primary Sources

List of Figures

Figure 1. Influenza Medication Product Picture

Figure 2. Global Influenza Medication Sales Market Share by Type in 2020 & 2026

Figure 3. Zanamivir Product Picture

Figure 4. Oseltamivir Product Picture

Figure 5. Peramivir Product Picture

Figure 6. Amantadine Product Picture

Figure 7. Rimantadine Product Picture

Figure 8. Inosine Product Picture

Figure 9. Other Product Picture

Figure 10. Global Influenza Medication Sales Market Share by Application in 2020 & 2026

Figure 11. Hospitals

Figure 12. Clinics

Figure 13. Pharmacies

Figure 14. Others

Figure 15. Influenza Medication Report Years Considered

Figure 16. Global Influenza Medication Market Size 2015-2026 (US$ Million)

Figure 17. Global Influenza Medication Sales 2015-2026 (K Units)

Figure 18. Global Influenza Medication Market Size Market Share by Region: 2020 Versus 2026

Figure 19. Global Influenza Medication Sales Market Share by Region (2015-2020)

Figure 20. Global Influenza Medication Sales Market Share by Region in 2019

Figure 21. Global Influenza Medication Revenue Market Share by Region (2015-2020)

Figure 22. Global Influenza Medication Revenue Market Share by Region in 2019

Figure 23. Global Influenza Medication Sales Share by Manufacturer in 2019

Figure 24. The Top 10 and 5 Players Market Share by Influenza Medication Revenue in 2019

Figure 25. Influenza Medication Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019

Figure 26. Global Influenza Medication Sales Market Share by Type (2015-2020)

Figure 27. Global Influenza Medication Sales Market Share by Type in 2019

Figure 28. Global Influenza Medication Revenue Market Share by Type (2015-2020)

Figure 29. Global Influenza Medication Revenue Market Share by Type in 2019

Figure 30. Global Influenza Medication Market Share by Price Range (2015-2020)

Figure 31. Global Influenza Medication Sales Market Share by Application (2015-2020)

Figure 32. Global Influenza Medication Sales Market Share by Application in 2019

Figure 33. Global Influenza Medication Revenue Market Share by Application (2015-2020)

Figure 34. Global Influenza Medication Revenue Market Share by Application in 2019

Figure 35. North America Influenza Medication Sales Growth Rate 2015-2020 (K Units)

Figure 36. North America Influenza Medication Revenue Growth Rate 2015-2020 (US$ Million)

Figure 37. North America Influenza Medication Sales Market Share by Country in 2019

Figure 38. North America Influenza Medication Revenue Market Share by Country in 2019

Figure 39. U.S. Influenza Medication Sales Growth Rate (2015-2020) (K Units)

Figure 40. U.S. Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)

Figure 41. Canada Influenza Medication Sales Growth Rate (2015-2020) (K Units)

Figure 42. Canada Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)

Figure 43. North America Influenza Medication Market Share by Type in 2019

Figure 44. North America Influenza Medication Market Share by Application in 2019

Figure 45. Europe Influenza Medication Sales Growth Rate 2015-2020 (K Units)

Figure 46. Europe Influenza Medication Revenue Growth Rate 2015-2020 (US$ Million)

Figure 47. Europe Influenza Medication Sales Market Share by Country in 2019

Figure 48. Europe Influenza Medication Revenue Market Share by Country in 2019

Figure 49. Germany Influenza Medication Sales Growth Rate (2015-2020) (K Units)

Figure 50. Germany Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)

Figure 51. France Influenza Medication Sales Growth Rate (2015-2020) (K Units)

Figure 52. France Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)

Figure 53. U.K. Influenza Medication Sales Growth Rate (2015-2020) (K Units)

Figure 54. U.K. Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)

Figure 55. Italy Influenza Medication Sales Growth Rate (2015-2020) (K Units)

Figure 56. Italy Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)

Figure 57. Russia Influenza Medication Sales Growth Rate (2015-2020) (K Units)

Figure 58. Russia Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)

Figure 59. Europe Influenza Medication Market Share by Type in 2019

Figure 60. Europe Influenza Medication Market Share by Application in 2019

Figure 61. Asia Pacific Influenza Medication Sales Growth Rate 2015-2020 (K Units)

Figure 62. Asia Pacific Influenza Medication Revenue Growth Rate 2015-2020 (US$ Million)

Figure 63. Asia Pacific Influenza Medication Sales Market Share by Region in 2019

Figure 64. Asia Pacific Influenza Medication Revenue Market Share by Region in 2019

Figure 65. China Influenza Medication Sales Growth Rate (2015-2020) (K Units)

Figure 66. China Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)

Figure 67. Japan Influenza Medication Sales Growth Rate (2015-2020) (K Units)

Figure 68. Japan Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)

Figure 69. South Korea Influenza Medication Sales Growth Rate (2015-2020) (K Units)

Figure 70. South Korea Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)

Figure 71. India Influenza Medication Sales Growth Rate (2015-2020) (K Units)

Figure 72. India Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)

Figure 73. Australia Influenza Medication Sales Growth Rate (2015-2020) (K Units)

Figure 74. Australia Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)

Figure 75. Taiwan Influenza Medication Sales Growth Rate (2015-2020) (K Units)

Figure 76. Taiwan Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)

Figure 77. Indonesia Influenza Medication Sales Growth Rate (2015-2020) (K Units)

Figure 78. Indonesia Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)

Figure 79. Thailand Influenza Medication Sales Growth Rate (2015-2020) (K Units)

Figure 80. Thailand Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)

Figure 81. Malaysia Influenza Medication Sales Growth Rate (2015-2020) (K Units)

Figure 82. Malaysia Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)

Figure 83. Philippines Influenza Medication Sales Growth Rate (2015-2020) (K Units)

Figure 84. Philippines Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)

Figure 85. Vietnam Influenza Medication Sales Growth Rate (2015-2020) (K Units)

Figure 86. Vietnam Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)

Figure 87. Asia Pacific Influenza Medication Market Share by Type in 2019

Figure 88. Asia Pacific Influenza Medication Market Share by Application in 2019

Figure 89. Latin America Influenza Medication Sales Growth Rate 2015-2020 (K Units)

Figure 90. Latin America Influenza Medication Revenue Growth Rate 2015-2020 (US$ Million)

Figure 91. Latin America Influenza Medication Sales Market Share by Country in 2019

Figure 92. Latin America Influenza Medication Revenue Market Share by Country in 2019

Figure 93. Mexico Influenza Medication Sales Growth Rate (2015-2020) (K Units)

Figure 94. Mexico Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)

Figure 95. Brazil Influenza Medication Sales Growth Rate (2015-2020) (K Units)

Figure 96. Brazil Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)

Figure 97. Argentina Influenza Medication Sales Growth Rate (2015-2020) (K Units)

Figure 98. Argentina Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)

Figure 99. Latin America Influenza Medication Market Share by Type in 2019

Figure 100. Latin America Influenza Medication Market Share by Application in 2019

Figure 101. Middle East and Africa Influenza Medication Sales Growth Rate 2015-2020 (K Units)

Figure 102. Middle East and Africa Influenza Medication Revenue Growth Rate 2015-2020 (US$ Million)

Figure 103. Middle East and Africa Influenza Medication Sales Market Share by Country in 2019

Figure 104. Middle East and Africa Influenza Medication Revenue Market Share by Country in 2019

Figure 105. Turkey Influenza Medication Sales Growth Rate (2015-2020) (K Units)

Figure 106. Turkey Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)

Figure 107. Saudi Arabia Influenza Medication Sales Growth Rate (2015-2020) (K Units)

Figure 108. Saudi Arabia Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)

Figure 109. U.A.E Influenza Medication Sales Growth Rate (2015-2020) (K Units)

Figure 110. U.A.E Influenza Medication Revenue Growth Rate (2015-2020) (US$ Million)

Figure 111. Middle East and Africa Influenza Medication Market Share by Type in 2019

Figure 112. Middle East and Africa Influenza Medication Market Share by Application in 2019

Figure 113. North America Influenza Medication Sales Growth Rate Forecast (2021-2026) (K Units)

Figure 114. North America Influenza Medication Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 115. Europe Influenza Medication Sales Growth Rate Forecast (2021-2026) (K Units)

Figure 116. Europe Influenza Medication Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 117. Asia Pacific Influenza Medication Sales Growth Rate Forecast (2021-2026) (K Units)

Figure 118. Asia Pacific Influenza Medication Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 119. Latin America Influenza Medication Sales Growth Rate Forecast (2021-2026) (K Units)

Figure 120. Latin America Influenza Medication Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 121. Middle East and Africa Influenza Medication Sales Growth Rate Forecast (2021-2026) (K Units)

Figure 122. Middle East and Africa Influenza Medication Revenue Growth Rate Forecast (2021-2026) (US$ Million)

Figure 123. Porter's Five Forces Analysis

Figure 124. Channels of Distribution

Figure 125. Distributors Profiles

Figure 126. Bottom-up and Top-down Approaches for This Report

Figure 127. Data Triangulation

Figure 128. Key Executives Interviewed

Daiichi Sankyo Company

GlaxoSmithKline

Natco Pharma

F. Hoffmann-La Roche

Teva Pharmaceutical

Sandoz International GmbH (Novartis AG)

Sun Pharmaceutical Industries

Mylan

CHOOSE YOUR BUYING OPTION COVID-19 Revised Pricing Of the Month

SECURITY ASSUREDpayment image

Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

CHECK TODAYS BEST PRICE

BEST PRICE: $3276

SOME OF OUR CLIENTS

OUR KEY POINTS

  • Comprehensive Research

    Offers Penetrative insights & holistic understanding of the market

  • Data Accuracy & Reliability

    Strictly follows the Research Meth-odology for flawless results

  • Competitive Pricing

    Ensure the best and affordable pricing

  • Security & Confidentiality

    All your transactions are secured end-to-end, ensuring a satisfactory purchase